Carcinogenic risk of products used in the pharmaceutical and related industries.
The pharmaceutical industry is perhaps most subject to rules and regulations in the majority of countries. Legislation in France in this regard is flexible and relatively easily adaptable; in addition, the pharmaceutical industry has established its own ground rules. One of these requires that a product be harmless under normal conditions of use; carcinogenicity checks are only mandatory under certain conditions. If they were to be made compulsory, a less unwieldy test system would be required. The use to which a product is put should be taken into consideration in regulating it.
D000336:Aerosols; D000348:Aflatoxins / Q000009:adverse effects; D001194:Asbestos / Q000009:adverse effects; D002273:Carcinogens / Q000032:analysis; D004396:Coloring Agents / Q000009:adverse effects; D003358:Cosmetics / Q000032:analysis; D003494:Cyclamates / Q000009:adverse effects; D004345:Drug Industry; D004349:Drug Packaging; D005505:Food Coloring Agents / Q000009:adverse effects; D006801:Humans; D009369:Neoplasms / Q000139:chemically induced / Q000209:etiology*; D011143:Polyvinyl Chloride / Q000009:adverse effects; D012439:Saccharin / Q000009:adverse effects; D013549:Sweetening Agents / Q000009:adverse effects; D014752:Vinyl Chloride / Q000009:adverse effects
D000336:Aerosols; D000348:Aflatoxins; D002273:Carcinogens; D004396:Coloring Agents; D003358:Cosmetics; D003494:Cyclamates; D005505:Food Coloring Agents; D013549:Sweetening Agents; D001194:Asbestos; D011143:Polyvinyl Chloride; D012439:Saccharin; D014752:Vinyl Chloride